IRCT20210519051345N23尚未招募未知
Bioequivalence study of Losartan 50mg capsule manufactured by Ronak Co. compared with innovator product
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- Male
入选标准
- •General Health (in terms of Liver, Heart and Kidney)
排除标准
- •History of cardiovascular disease, liver and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
招募中
不适用
Investigating the in vivo bioequivalence of losartan 50 mgIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N4Tabriz University of Medical Sciences24
已完成
不适用
A bioequivalence study of losartan H 50/12.5 mg tablet compared to Hyzaar 50/12.5 mg tablet manufactured by Merck in 24 healthy volunteers under fasting conditioBlood concentration of test and reference drug is compared.IRCT20220209053979N2Alborz Darou24
招募中
不适用
Bioequivalence Evaluation of Losartan and Cozaar® formulations in healthy volunteersIRCT20130603013572N5Daana pharma.Co26
尚未招募
Unknown
Bioequivalence study of Losar H® 50/12.5 mg in 24 healthy male under fasting conditionsIRCT20180620040164N47Razak Pharmaceutical Co.24
已完成
不适用
Bioequivalency Study of Losartan Potassium 100 mg Tablet Under Fasted ConditionsHypertensionNCT01216852Roxane Laboratories40